In 2023, China's share of scientific publications among the world's top 10% cited in immunology and microbiology was a key metric, which the subsequent forecasted data suggests will experience a steady upward trend. From 2024 to 2028, forecast values show an increase from 9.88% to 11.19%, indicating a consistent year-on-year growth. The compound annual growth rate (CAGR) over this period reflects a positive average increase in recognition and impact of Chinese research within these fields.

Future trends to watch for:

Continued investment in scientific research and development within China, potentially leading to more groundbreaking publications.
Enhancement of international collaborations to further boost citation impacts.
Increasing focus on innovation and novel research areas in immunology and microbiology.